Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC6A11 | P48066 | 8/20 | 0.45 |
| ▸ | SLC6A1 | P30531 | 3/20 | 0.45 |
| ▸ | SLC6A12 | P48065 | 2/20 | 0.40 |
| ▸ | TP53 | P04637 | 2/20 | 0.40 |
| ▸ | MEN1 | O00255 | 1/20 | 0.40 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.40 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.40 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.40 |
| ▸ | SLC6A13 | Q9NSD5 | 1/20 | 0.40 |
| ▸ | TYMP | P19971 | 1/20 | 0.39 |
| ▸ | KIF11 | P52732 | 1/20 | 0.37 |
| ▸ | RIPK1 | Q13546 | 1/20 | 0.37 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.36 |
| ▸ | LMNA | P02545 | 2/20 | 0.36 |
| ▸ | MAPT | P10636 | 2/20 | 0.36 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19463293 | 0.91 | SLC6A11 (0.46) | SLC6A11SLC6A1SLC6A12TP53MEN1 | |
| SCHEMBL3088920 | 0.89 | SLC6A11 (0.48) | SLC6A11SLC6A1SLC6A12TP53MEN1 | |
| SCHEMBL9908646 | 0.89 | SLC6A11 (0.47) | SLC6A11SLC6A1SLC6A12TP53MEN1 | |
| SCHEMBL8662709 | 0.86 | MTNR1B (0.37) | SLC6A11SLC6A1TP53MEN1KMT2A | |
| SCHEMBL16248722 | 0.85 | SLC6A11 (0.44) | SLC6A11SLC6A1SLC6A12TP53MEN1 | |
| SCHEMBL8662717 | 0.84 | MTNR1B (0.37) | SLC6A1SLC6A12TP53MEN1KMT2A | |
| SCHEMBL12248426 | 0.83 | POLB (0.46) | SLC6A11SLC6A1SLC6A12TP53MEN1 | |
| SCHEMBL764125 | 0.82 | SLC6A11 (0.52) | SLC6A11SLC6A1SLC6A12TP53MEN1 | |
| SCHEMBL24383294 | 0.82 | SLC6A11 (0.42) | SLC6A11SLC6A1SLC6A12TP53MEN1 | |
| SCHEMBL9604514 | 0.82 | SLC6A11 (0.42) | SLC6A11SLC6A1SLC6A12TP53MEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20150196655-A1 | CARBOHYDRATE CONJUGATED RNA AGENTS AND PROCESS FOR THEIR PREPARATION | BANK OF AMERICA, N.A. | 2015-07-16 | — | — | US | disclosed |
| US-20150196655-A1 | CARBOHYDRATE CONJUGATED RNA AGENTS AND PROCESS FOR THEIR PREPARATION | BANK OF AMERICA, N.A. | 2015-07-16 | — | — | US | disclosed |
| WO-2014025805-A1 | CARBOHYDRATE CONJUGATED RNA AGENTS AND PROCESS FOR THEIR PREPARATION | ALNYLAM PHARMACEUTICALS, INC. (US) | 2014-02-13 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150196655-A1 | CARBOHYDRATE CONJUGATED RNA AGENTS AND PROCESS FOR THEIR PREPARATION | RNASE1, IGF2BP1, IGF2BP2 | SLC6A11 4095/4885SLC6A1 4277/4885SLC6A12 3238/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.